Cephalalgia
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.8 | Q1 | 90.5% | 1.178 | Q1 | 87.7% |
| 2024 | 4.6 | Q1 | 86.3% | 1.367 | Q1 | 90.8% |
| 2023 | 5.0 | Q1 | 84.7% | 1.382 | Q1 | 91.6% |
| 2022 | 4.9 | Q1 | 73.9% | 1.561 | Q1 | 93.4% |
| 2021 | 6.1 | Q1 | 81.2% | 1.805 | Q1 | 95.1% |
| 2020 | — | — | 1.570 | Q1 | 93.0% | |
| 2019 | — | — | 1.670 | Q1 | 93.9% | |
| 2018 | — | — | 1.617 | Q1 | 92.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0333-1024
ISSN
1468-2982
region
Western Europe
coverage
1981-2026